US Broker Ratings

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Unpacking the 176% Revenue Growth and Robust Pipeline

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a pioneer in the biotechnology sector, is capturing the attention of investors with its remarkable 176% revenue growth. Based in South..

Canopy Growth Corporation (CGC) Stock Analysis: Navigating a Challenging Market with Strategic Positioning

Canopy Growth Corporation (NASDAQ: CGC) is a prominent player in the healthcare sector, specifically within the niche of drug manufacturers specializing in cannabis and related products...

Applovin Corporation (APP) Stock Analysis: Evaluating the Robust Growth and Market Position

Applovin Corporation (NASDAQ: APP) has been making significant waves in the communication services sector, specifically within the advertising agencies industry. Headquartered in Palo Alto, California, Applovin..

Absci Corporation (ABSI) Stock Analysis: Potential 241% Upside Makes This AI-Driven Biotech a Compelling Play

Absci Corporation (NASDAQ: ABSI) is an intriguing player in the biotechnology sector, leveraging cutting-edge artificial intelligence (AI) to revolutionize drug creation. Despite facing some financial turbulence,..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Unveiling a 30% Upside Potential in the Medical Devices Arena

Cytek Biosciences, Inc. (NASDAQ: CTKB) stands as a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Fremont, California, Cytek Biosciences..

Quantum-Si (QSI) Stock Analysis: Exploring a 149% Potential Upside in Next-Gen Protein Sequencing

Quantum-Si Incorporated (NASDAQ: QSI), a pioneering force in the healthcare sector’s medical devices industry, is making waves with its innovative approach to protein sequencing. Headquartered in..

Aura Biosciences, Inc. (AURA) Stock Analysis: Exploring a 231% Potential Upside in the Biotech Sector

Aura Biosciences, Inc. (NASDAQ: AURA) presents a compelling opportunity for investors looking to capitalize on the burgeoning biotechnology sector. Headquartered in Boston, Massachusetts, this clinical-stage biotech..

Neurogene Inc. (NGNE): Analyst Consensus Highlights 138% Potential Upside for Biotech Innovator

In the ever-evolving landscape of biotechnology, Neurogene Inc. (NASDAQ: NGNE) stands out as a company with significant potential upside, according to recent analyst ratings. With a..

Nyxoah SA (NYXH) Stock Analysis: A Healthcare Innovator with 116% Potential Upside

For investors seeking opportunities in the healthcare sector, Nyxoah SA (NASDAQ: NYXH) presents an intriguing prospect. As a Belgian-based medical technology company specializing in solutions for..

XOMA Royalty Corporation (XOMA): Unpacking the 85.5% Potential Upside Amidst Biotech Innovation

XOMA Royalty Corporation (NASDAQ: XOMA) is capturing investor attention with its compelling 85.5% potential upside, as reflected in recent analyst target price ranges. As a unique..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Navigating a 98.69% Potential Upside in the Biotechnology Sector

Tvardi Therapeutics, Inc. (NASDAQ: TVRD) is capturing the attention of investors with its robust potential upside of 98.69%, positioning itself as a promising contender in the..

Marti Technologies, Inc. (MRT) Stock Analysis: 115% Potential Upside Ignites Investor Interest

Marti Technologies, Inc. (NASDAQ: MRT) is a rising player in the tech-enabled urban transportation sector, headquartered in the vibrant city of Istanbul, Turkey. Specializing in software..

Nano-X Imaging Ltd (NNOX) Stock Analysis: Exploring a Promising 106.67% Upside Potential in the Medical Device Sector

In the ever-evolving landscape of medical technology, Nano-X Imaging Ltd (NASDAQ: NNOX) stands out as a disruptive force within the healthcare sector. Specializing in innovative imaging..

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring a 216% Potential Upside in the Medical Device Sector

Senseonics Holdings, Inc. (NYSE: SENS), a key player in the healthcare sector, is making waves in the medical device industry with its innovative continuous glucose monitoring..

Aurora Cannabis Inc. (ACB) Stock Analysis: Exploring a 28.65% Potential Upside for Investors

Aurora Cannabis Inc. (NASDAQ: ACB) stands as a prominent player within the healthcare sector, specifically in the drug manufacturing industry, specializing in both specialty and generic..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Is a 247.74% Upside Within Reach for Investors?

As investors navigate the volatile biotechnology sector, Entrada Therapeutics, Inc. (NASDAQ: TRDA) presents a particularly intriguing opportunity. With a market capitalization of $202.36 million, this Boston-based..

Benitec Biopharma Inc. (BNTC) Stock Analysis: An 84.86% Upside Potential Beckons Investors

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company, is capturing investor attention with a standout potential upside of 84.86%. Positioned in the healthcare sector, this..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Exploring a Biotech Gem with Potential 306.57% Upside

In the realm of biotechnology, few companies capture investor attention as dynamically as Arcturus Therapeutics Holdings (NASDAQ: ARCT). This San Diego-based firm is making waves in..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Exploring a 69.81% Potential Upside in the Biotechnology Space

Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a burgeoning name in the biotechnology sector, has been garnering attention for its innovative approach to treating genetically defined diseases. Headquartered..

Harrow, Inc. (HROW) Stock Analysis: Evaluating Robust Growth with 54.10% Upside Potential

Harrow, Inc. (NASDAQ: HROW) is capturing the attention of investors in the healthcare sector, particularly within the niche of ophthalmic pharmaceuticals. With a market capitalization of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds